Proton Pump Inhibitor [EPC]

Proton Pump Inhibitor [EPC] was reported 578459 times

These side effects are most commonly reported by patients taking drugs of the Proton Pump Inhibitor [EPC] class:

# Drug class Count
0 CHRONIC KIDNEY DISEASE 37799
1 NAUSEA 34733
2 DIARRHOEA 33923
3 FATIGUE 32889
4 DYSPNOEA 28752
5 ACUTE KIDNEY INJURY 28500
6 DRUG INEFFECTIVE 27903
7 HEADACHE 26203
8 OFF LABEL USE 24760
9 PAIN 24067
10 VOMITING 23617
11 DIZZINESS 22050
12 MALAISE 19833
13 ARTHRALGIA 19593
14 RENAL FAILURE 19110
15 ASTHENIA 18604
16 PNEUMONIA 17259
17 FALL 17186
18 PYREXIA 16970
19 RASH 15442
20 DEATH 15381
21 COUGH 14520
22 ABDOMINAL PAIN 14323
23 PRURITUS 14124
24 WEIGHT DECREASED 13682
25 PAIN IN EXTREMITY 13373
26 DRUG INTERACTION 12934
27 ABDOMINAL PAIN UPPER 12675
28 CONDITION AGGRAVATED 12619
29 DECREASED APPETITE 12320
30 ANXIETY 12089
31 CONSTIPATION 11825
32 BACK PAIN 11488
33 INSOMNIA 11350
34 CHEST PAIN 11212
35 ANAEMIA 11199
36 HYPERTENSION 11100
37 CONFUSIONAL STATE 10976
38 END STAGE RENAL DISEASE 10944
39 DEPRESSION 10358
40 RENAL INJURY 10256
41 HYPOTENSION 10208
42 GASTROOESOPHAGEAL REFLUX DISEASE 10003
43 URINARY TRACT INFECTION 9362
44 ABDOMINAL DISCOMFORT 8818
45 MUSCLE SPASMS 8656
46 PERIPHERAL SWELLING 8543
47 WEIGHT INCREASED 8498
48 SOMNOLENCE 8376
49 FEELING ABNORMAL 8143
50 GAIT DISTURBANCE 7938
51 MYALGIA 7920
52 DEHYDRATION 7840
53 NASOPHARYNGITIS 7673
54 ALOPECIA 7408
55 OEDEMA PERIPHERAL 7385
56 PARAESTHESIA 7175
57 HYPONATRAEMIA 7057
58 PRODUCT USE IN UNAPPROVED INDICATION 7053
59 TREMOR 7046
60 DYSPEPSIA 7011
61 BLOOD PRESSURE INCREASED 6803
62 HYPERSENSITIVITY 6762
63 PRODUCT DOSE OMISSION ISSUE 6638
64 HYPOAESTHESIA 6623
65 JOINT SWELLING 6561
66 ERYTHEMA 6560
67 DRUG HYPERSENSITIVITY 6515
68 ASTHMA 6408
69 SEPSIS 6394
70 URTICARIA 6377
71 INFECTION 6364
72 MUSCULAR WEAKNESS 6351
73 COVID-19 6159
74 HYPERHIDROSIS 6070
75 TUBULOINTERSTITIAL NEPHRITIS 6047
76 SINUSITIS 5976
77 RENAL IMPAIRMENT 5934
78 GENERAL PHYSICAL HEALTH DETERIORATION 5843
79 MEMORY IMPAIRMENT 5758
80 PALPITATIONS 5704
81 ATRIAL FIBRILLATION 5668
82 HAEMOGLOBIN DECREASED 5635
83 THROMBOCYTOPENIA 5622
84 CONTUSION 5592
85 RHEUMATOID ARTHRITIS 5509
86 ABDOMINAL DISTENSION 5486
87 PRODUCT USE ISSUE 5429
88 NEUTROPENIA 5426
89 SYNCOPE 5407
90 INJECTION SITE PAIN 5382
91 MYOCARDIAL INFARCTION 5276
92 CEREBROVASCULAR ACCIDENT 5254
93 DRY MOUTH 5230
94 VISION BLURRED 5125
95 DYSPHAGIA 5117
96 LOSS OF CONSCIOUSNESS 5093
97 ARTHRITIS 4946
98 LOWER RESPIRATORY TRACT INFECTION 4921
99 BALANCE DISORDER 4919
100 MUSCULOSKELETAL STIFFNESS 4900
101 SWELLING 4870
102 CHEST DISCOMFORT 4862
103 CHILLS 4735
104 PULMONARY EMBOLISM 4703
105 PLATELET COUNT DECREASED 4695
106 GASTROINTESTINAL DISORDER 4665
107 INFLUENZA 4651
108 GASTROINTESTINAL HAEMORRHAGE 4629
109 WHEEZING 4619
110 BLOOD GLUCOSE INCREASED 4603
111 TACHYCARDIA 4601
112 TOXICITY TO VARIOUS AGENTS 4544
113 MIGRAINE 4532
114 HEART RATE INCREASED 4524
115 OROPHARYNGEAL PAIN 4484
116 NEUROPATHY PERIPHERAL 4456
117 HYPOKALAEMIA 4453
118 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4318
119 DRUG INTOLERANCE 4276
120 MOBILITY DECREASED 4268
121 WHITE BLOOD CELL COUNT DECREASED 4226
122 VISUAL IMPAIRMENT 4194
123 BLOOD CREATININE INCREASED 4128
124 BRONCHITIS 4092
125 INCORRECT DOSE ADMINISTERED 4041
126 INTENTIONAL PRODUCT USE ISSUE 3962
127 HALLUCINATION 3919
128 HYPOMAGNESAEMIA 3869
129 FEBRILE NEUTROPENIA 3858
130 CARDIAC FAILURE 3840
131 INFUSION RELATED REACTION 3785
132 OVERDOSE 3771
133 SEIZURE 3749
134 DRUG DOSE OMISSION 3744
135 RESPIRATORY FAILURE 3723
136 SLEEP DISORDER 3701
137 PSORIASIS 3693
138 OSTEOARTHRITIS 3660
139 ARTHROPATHY 3657
140 STOMATITIS 3625
141 FLUSHING 3531
142 ALANINE AMINOTRANSFERASE INCREASED 3526
143 EPISTAXIS 3466
144 CARDIAC FAILURE CONGESTIVE 3459
145 OEDEMA 3451
146 HEPATIC ENZYME INCREASED 3440
147 AMNESIA 3434
148 MUSCULOSKELETAL PAIN 3425
149 DIABETES MELLITUS 3422
150 BLISTER 3409
151 PLEURAL EFFUSION 3361
152 BLOOD CHOLESTEROL INCREASED 3352
153 HOSPITALISATION 3339
154 RENAL FAILURE ACUTE 3333
155 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3329
156 DISEASE PROGRESSION 3293
157 ILLNESS 3250
158 OXYGEN SATURATION DECREASED 3234
159 SWELLING FACE 3234
160 DRY SKIN 3228
161 PANCYTOPENIA 3224
162 RECTAL HAEMORRHAGE 3181
163 DISCOMFORT 3147
164 LUNG DISORDER 3143
165 DEEP VEIN THROMBOSIS 3104
166 LETHARGY 3092
167 THROMBOSIS 3082
168 INFLAMMATION 3074
169 NECK PAIN 3066
170 FLATULENCE 3037
171 STRESS 2999
172 DYSGEUSIA 2967
173 DYSPHONIA 2946
174 BLOOD PRESSURE DECREASED 2942
175 HAEMORRHAGE 2942
176 INTERSTITIAL LUNG DISEASE 2937
177 PRODUCTIVE COUGH 2928
178 BURNING SENSATION 2923
179 CARDIAC ARREST 2919
180 CARDIAC DISORDER 2917
181 RHINORRHOEA 2915
182 AGITATION 2859
183 OSTEOPOROSIS 2850
184 HYPERKALAEMIA 2842
185 INTENTIONAL PRODUCT MISUSE 2832
186 NEPHROLITHIASIS 2831
187 VERTIGO 2812
188 CATARACT 2811
189 INJURY 2811
190 TINNITUS 2808
191 ASPARTATE AMINOTRANSFERASE INCREASED 2795
192 HOT FLUSH 2795
193 BRADYCARDIA 2790
194 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2779
195 SUICIDAL IDEATION 2769
196 CELLULITIS 2760
197 HYPOCALCAEMIA 2750
198 INFLUENZA LIKE ILLNESS 2732
199 LIVER DISORDER 2687
200 ANGIOEDEMA 2682
201 COGNITIVE DISORDER 2680
202 C-REACTIVE PROTEIN INCREASED 2672
203 FIBROMYALGIA 2669
204 TYPE 2 DIABETES MELLITUS 2665
205 NEPHROGENIC ANAEMIA 2655
206 PANCREATITIS 2614
207 RHABDOMYOLYSIS 2606
208 MALIGNANT NEOPLASM PROGRESSION 2601
209 GASTRITIS 2598
210 PSORIATIC ARTHROPATHY 2587
211 HYPOGLYCAEMIA 2585
212 UPPER RESPIRATORY TRACT INFECTION 2578
213 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2573
214 FEELING HOT 2565
215 RENAL DISORDER 2543
216 CROHN^S DISEASE 2537
217 RASH PRURITIC 2513
218 NASAL CONGESTION 2509
219 HAEMATURIA 2501
220 PRODUCT QUALITY ISSUE 2492
221 SEPTIC SHOCK 2484
222 EYE PAIN 2483
223 DYSPNOEA EXERTIONAL 2470
224 HAEMATOCHEZIA 2458
225 BONE PAIN 2452
226 EMOTIONAL DISTRESS 2434
227 MEDICATION ERROR 2407
228 SKIN EXFOLIATION 2407
229 DISTURBANCE IN ATTENTION 2405
230 DELIRIUM 2394
231 SYSTEMIC LUPUS ERYTHEMATOSUS 2388
232 IMPAIRED HEALING 2380
233 ADVERSE DRUG REACTION 2360
234 DYSURIA 2360
235 ANAPHYLACTIC REACTION 2333
236 SWOLLEN TONGUE 2307
237 FLUID RETENTION 2301
238 WHITE BLOOD CELL COUNT INCREASED 2290
239 ELECTROCARDIOGRAM QT PROLONGED 2283
240 MATERNAL EXPOSURE DURING PREGNANCY 2263
241 INJECTION SITE ERYTHEMA 2258
242 LIP SWELLING 2247
243 HYPERCHLORHYDRIA 2241
244 TRANSIENT ISCHAEMIC ATTACK 2207
245 DEPRESSED MOOD 2206
246 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2206
247 WOUND 2190
248 HERPES ZOSTER 2188
249 LIVER FUNCTION TEST ABNORMAL 2188
250 HAEMATEMESIS 2176
251 PULMONARY OEDEMA 2170
252 NIGHT SWEATS 2151
253 ILL-DEFINED DISORDER 2137
254 IRRITABLE BOWEL SYNDROME 2137
255 PERICARDITIS 2121
256 THROAT IRRITATION 2119
257 TREATMENT FAILURE 2115
258 INTERNATIONAL NORMALISED RATIO INCREASED 2114
259 LEUKOPENIA 2086
260 ADVERSE EVENT 2075
261 NO ADVERSE EVENT 2072
262 CHOLELITHIASIS 2071
263 POLLAKIURIA 2066
264 REBOUND ACID HYPERSECRETION 2064
265 GLOSSODYNIA 2042
266 HYPOXIA 2041
267 SPEECH DISORDER 2009
268 DEPRESSED LEVEL OF CONSCIOUSNESS 2002
269 DYSARTHRIA 1994
270 DISORIENTATION 1991
271 ASCITES 1990
272 METABOLIC ACIDOSIS 1981
273 ROAD TRAFFIC ACCIDENT 1957
274 ORTHOSTATIC HYPOTENSION 1954
275 DRY EYE 1946
276 URINARY RETENTION 1943
277 COLITIS 1928
278 ARRHYTHMIA 1923
279 PULMONARY FIBROSIS 1915
280 CONTRAINDICATED PRODUCT ADMINISTERED 1910
281 SYNOVITIS 1910
282 THERAPY NON-RESPONDER 1899
283 BLOOD POTASSIUM DECREASED 1876
284 CARDIO-RESPIRATORY ARREST 1871
285 GAIT INABILITY 1871
286 LIVER INJURY 1871
287 NIGHTMARE 1852
288 HYPERGLYCAEMIA 1842
289 HAEMOPTYSIS 1841
290 THERAPEUTIC PRODUCT EFFECT DECREASED 1841
291 UNEVALUABLE EVENT 1837
292 HYPOTHYROIDISM 1832
293 NEUTROPHIL COUNT DECREASED 1831
294 RASH ERYTHEMATOUS 1810
295 NERVOUSNESS 1796
296 PANCREATITIS ACUTE 1771
297 NEPHROPATHY 1767
298 REBOUND EFFECT 1754
299 URINARY INCONTINENCE 1748
300 ANGINA PECTORIS 1746
301 ACUTE MYOCARDIAL INFARCTION 1739
302 SKIN DISCOLOURATION 1719
303 CORONARY ARTERY DISEASE 1713
304 INTESTINAL OBSTRUCTION 1712
305 MELAENA 1710
306 BLOOD ALKALINE PHOSPHATASE INCREASED 1694
307 HELICOBACTER INFECTION 1691
308 PRODUCT SUBSTITUTION ISSUE 1691
309 APHASIA 1677
310 DIPLOPIA 1642
311 JAUNDICE 1640
312 HEART RATE DECREASED 1634
313 SLEEP APNOEA SYNDROME 1633
314 PRODUCT DOSE OMISSION 1630
315 CYSTITIS 1629
316 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1628
317 SURGERY 1626
318 DIVERTICULITIS 1615
319 CHOLESTASIS 1614
320 SEDATION 1613
321 COMA 1611
322 DRUG DEPENDENCE 1608
323 HIATUS HERNIA 1603
324 GASTRIC DISORDER 1600
325 DYSKINESIA 1599
326 CONVULSION 1596
327 DIALYSIS 1596
328 BURSITIS 1589
329 IRRITABILITY 1586
330 SKIN ULCER 1583
331 INTENTIONAL OVERDOSE 1575
332 HEPATIC FUNCTION ABNORMAL 1570
333 THERAPY INTERRUPTED 1570
334 COLITIS ULCERATIVE 1559
335 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1556
336 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1556
337 STAPHYLOCOCCAL INFECTION 1555
338 THERAPEUTIC RESPONSE DECREASED 1555
339 TREATMENT NONCOMPLIANCE 1548
340 ECZEMA 1545
341 BLINDNESS 1537
342 RESPIRATORY TRACT INFECTION 1536
343 HAND DEFORMITY 1525
344 INJECTION SITE BRUISING 1511
345 PNEUMONIA ASPIRATION 1510
346 RED BLOOD CELL COUNT DECREASED 1506
347 LACTIC ACIDOSIS 1503
348 RESPIRATORY DISORDER 1502
349 MUCOSAL INFLAMMATION 1494
350 OBESITY 1493
351 DRUG-INDUCED LIVER INJURY 1484
352 UPPER GASTROINTESTINAL HAEMORRHAGE 1473
353 CEREBRAL HAEMORRHAGE 1472
354 BLOOD PRESSURE SYSTOLIC INCREASED 1471
355 LOWER LIMB FRACTURE 1467
356 HEAD INJURY 1466
357 COMPLETED SUICIDE 1458
358 VIRAL INFECTION 1457
359 FOLLICULITIS 1452
360 HYPOPHAGIA 1443
361 PRESYNCOPE 1440
362 DUODENAL ULCER PERFORATION 1438
363 RASH MACULO-PAPULAR 1435
364 EYE IRRITATION 1429
365 PNEUMONITIS 1429
366 SUICIDE ATTEMPT 1427
367 SCIATICA 1424
368 FAECES DISCOLOURED 1419
369 CHROMATURIA 1417
370 LYMPHADENOPATHY 1415
371 BLOOD CREATINE PHOSPHOKINASE INCREASED 1413
372 MOUTH ULCERATION 1411
373 BLOOD PRESSURE FLUCTUATION 1409
374 JOINT RANGE OF MOTION DECREASED 1407
375 DISEASE RECURRENCE 1399
376 HEPATITIS 1399
377 NEURALGIA 1399
378 PEMPHIGUS 1399
379 INCORRECT PRODUCT ADMINISTRATION DURATION 1397
380 FREQUENT BOWEL MOVEMENTS 1387
381 MUSCLE TWITCHING 1386
382 RASH MACULAR 1383
383 AGRANULOCYTOSIS 1378
384 HEPATIC STEATOSIS 1375
385 ULCER 1370
386 HAEMATOMA 1360
387 PROTEINURIA 1360
388 SEROTONIN SYNDROME 1355
389 BLOOD BILIRUBIN INCREASED 1354
390 EAR INFECTION 1351
391 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1350
392 UNDERDOSE 1350
393 CLOSTRIDIUM DIFFICILE INFECTION 1344
394 INJECTION SITE HAEMORRHAGE 1336
395 GASTRIC ULCER 1333
396 HEPATIC FAILURE 1333
397 INJECTION SITE PRURITUS 1332
398 MUSCLE INJURY 1328
399 ORAL PAIN 1318
400 BLOOD SODIUM DECREASED 1312
401 PAIN IN JAW 1308
402 TOXIC EPIDERMAL NECROLYSIS 1300
403 RESPIRATORY DISTRESS 1298
404 AGGRESSION 1293
405 EOSINOPHILIA 1291
406 DEVICE ISSUE 1289
407 LIMB INJURY 1289
408 ACUTE RESPIRATORY FAILURE 1285
409 THERAPY CESSATION 1282
410 EXPOSURE DURING PREGNANCY 1281
411 RESTLESSNESS 1281
412 INJECTION SITE SWELLING 1277
413 JOINT STIFFNESS 1271
414 PANIC ATTACK 1271
415 NEOPLASM MALIGNANT 1269
416 PLASMA CELL MYELOMA 1268
417 FUNGAL INFECTION 1264
418 BLOOD CALCIUM DECREASED 1258
419 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1253
420 SKIN LESION 1253
421 INJECTION SITE REACTION 1248
422 LIMB DISCOMFORT 1244
423 PALLOR 1239
424 VENTRICULAR TACHYCARDIA 1228
425 HIP FRACTURE 1227
426 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1224
427 BLOOD UREA INCREASED 1224
428 BLOOD GLUCOSE DECREASED 1222
429 MENTAL DISORDER 1221
430 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1220
431 INTERVERTEBRAL DISC PROTRUSION 1216
432 HEPATIC CIRRHOSIS 1214
433 KIDNEY INFECTION 1212
434 MULTIPLE SCLEROSIS RELAPSE 1211
435 PULMONARY HYPERTENSION 1209
436 PERICARDIAL EFFUSION 1206
437 THERAPEUTIC RESPONSE UNEXPECTED 1205
438 HAEMATOCRIT DECREASED 1203
439 EATING DISORDER 1199
440 FEMUR FRACTURE 1198
441 DYSSTASIA 1193
442 RIB FRACTURE 1192
443 HAEMORRHOIDS 1190
444 EPILEPSY 1189
445 PRESCRIBED OVERDOSE 1188
446 FEELING COLD 1183
447 OCULAR HYPERAEMIA 1183
448 C-REACTIVE PROTEIN ABNORMAL 1173
449 MENTAL STATUS CHANGES 1173
450 MOVEMENT DISORDER 1170
451 EYE PRURITUS 1169
452 ALTERED STATE OF CONSCIOUSNESS 1168
453 HYPERPARATHYROIDISM SECONDARY 1165
454 WOUND INFECTION 1163
455 DRUG EFFECT DECREASED 1161
456 OESOPHAGITIS 1158
457 HYPERSOMNIA 1149
458 FOETAL EXPOSURE DURING PREGNANCY 1140
459 EYE SWELLING 1136
460 ENCEPHALOPATHY 1135
461 UNRESPONSIVE TO STIMULI 1135
462 IMPAIRED GASTRIC EMPTYING 1134
463 RESTLESS LEGS SYNDROME 1132
464 RHEUMATOID FACTOR POSITIVE 1106
465 KNEE ARTHROPLASTY 1103
466 OSTEOPENIA 1103
467 RENAL CYST 1103
468 CARPAL TUNNEL SYNDROME 1101
469 HEART RATE IRREGULAR 1098
470 SINUS DISORDER 1097
471 LIP DRY 1094
472 HYPOACUSIS 1092
473 EAR PAIN 1091
474 HEMIPARESIS 1089
475 CIRCULATORY COLLAPSE 1085
476 LOCALISED INFECTION 1085
477 THROAT TIGHTNESS 1083
478 ABNORMAL BEHAVIOUR 1081
479 DRUG WITHDRAWAL SYNDROME 1080
480 HALLUCINATION, VISUAL 1071
481 HYPERCHOLESTEROLAEMIA 1069
482 SKIN DISORDER 1069
483 DRUG ABUSE 1063
484 JOINT INJURY 1063
485 ANHEDONIA 1062
486 MUSCULOSKELETAL CHEST PAIN 1038
487 COORDINATION ABNORMAL 1035
488 PHOTOPHOBIA 1035
489 NEUTROPENIC SEPSIS 1033
490 BLOOD TEST ABNORMAL 1024
491 TASTE DISORDER 1023
492 HYPERLIPIDAEMIA 1022
493 GOUT 1021
494 INCORRECT DRUG ADMINISTRATION DURATION 1021
495 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1014
496 FOOT FRACTURE 1013
497 GASTROENTERITIS 1012
498 CEREBRAL INFARCTION 1010
499 LACRIMATION INCREASED 1010
500 WITHDRAWAL SYNDROME 1010
501 DEVICE MALFUNCTION 1009
502 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1009
503 DEMENTIA 1005
504 IRON DEFICIENCY ANAEMIA 1004
505 BONE DISORDER 996
506 DRUG ERUPTION 996
507 HEPATIC CYTOLYSIS 993
508 RASH PAPULAR 993
509 TOOTH DISORDER 993
510 BREAST CANCER 990
511 ERUCTATION 990
512 AUTOIMMUNE DISORDER 989
513 ACCIDENTAL OVERDOSE 982
514 TENDONITIS 980
515 RETCHING 979
516 AGEUSIA 976
517 BODY TEMPERATURE INCREASED 975
518 CRYING 975
519 PRESCRIBED UNDERDOSE 971
520 GALLBLADDER DISORDER 969
521 TRANSAMINASES INCREASED 968
522 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 967
523 LEUKOCYTOSIS 966
524 RASH GENERALISED 966
525 BACTERIAL INFECTION 965
526 MULTIPLE SCLEROSIS 962
527 NOCTURIA 961
528 STEVENS-JOHNSON SYNDROME 961
529 RHEUMATIC FEVER 956
530 LABORATORY TEST ABNORMAL 953
531 LIVER FUNCTION TEST INCREASED 951
532 HEPATOCELLULAR INJURY 950
533 SEASONAL ALLERGY 947
534 HEAD DISCOMFORT 945
535 DRUG LEVEL INCREASED 943
536 FEEDING DISORDER 941
537 BASAL CELL CARCINOMA 937
538 SNEEZING 930
539 VITAMIN D DEFICIENCY 928
540 BLOOD POTASSIUM INCREASED 923
541 POOR QUALITY SLEEP 921
542 ORAL CANDIDIASIS 920
543 LYMPHOCYTE COUNT DECREASED 915
544 DEAFNESS 912
545 SUBARACHNOID HAEMORRHAGE 912
546 SPINAL FRACTURE 909
547 PSYCHOTIC DISORDER 908
548 HERNIA 907
549 CANDIDA INFECTION 903
550 ISCHAEMIC STROKE 903
551 CLOSTRIDIUM DIFFICILE COLITIS 900
552 ABDOMINAL PAIN LOWER 899
553 PULMONARY MASS 899
554 ABNORMAL DREAMS 896
555 VASCULITIS 895
556 BLOOD MAGNESIUM DECREASED 892
557 ACNE 889
558 WRONG TECHNIQUE IN DRUG USAGE PROCESS 887
559 LUNG NEOPLASM MALIGNANT 886
560 RENAL TUBULAR NECROSIS 886
561 PAIN OF SKIN 885
562 PRURITUS GENERALISED 884
563 BACK DISORDER 880
564 HYPOPHOSPHATAEMIA 880
565 MOOD SWINGS 880
566 EYE DISORDER 877
567 CHOKING 872
568 VISUAL ACUITY REDUCED 871
569 ERECTILE DYSFUNCTION 864
570 ABASIA 857
571 GASTROENTERITIS VIRAL 857
572 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 857
573 ACUTE RESPIRATORY DISTRESS SYNDROME 854
574 ELECTROLYTE IMBALANCE 854
575 FOOT DEFORMITY 853
576 HIP ARTHROPLASTY 852
577 CARDIOMEGALY 847
578 ANGER 846
579 SUBDURAL HAEMATOMA 846
580 MUSCULOSKELETAL DISCOMFORT 842
581 SINUS CONGESTION 842
582 HEPATOTOXICITY 840
583 SKIN BURNING SENSATION 837
584 SPINAL OSTEOARTHRITIS 837
585 COAGULOPATHY 833
586 MULTI-ORGAN FAILURE 833
587 SWOLLEN JOINT COUNT INCREASED 833
588 OSTEONECROSIS OF JAW 831
589 MALNUTRITION 830
590 BONE DENSITY DECREASED 829
591 IMPAIRED QUALITY OF LIFE 828
592 ASPIRATION 824
593 BLOOD PRESSURE ABNORMAL 822
594 EMOTIONAL DISORDER 820
595 HYPERCALCAEMIA 820
596 CYTOKINE RELEASE SYNDROME 819
597 DIABETES MELLITUS INADEQUATE CONTROL 819
598 RESPIRATORY TRACT CONGESTION 819
599 ATELECTASIS 816
600 GENERALISED OEDEMA 816
601 CHOLECYSTITIS 811
602 NEOPLASM PROGRESSION 810
603 FEAR 808
604 PERIPHERAL VENOUS DISEASE 806
605 OBSTRUCTIVE AIRWAYS DISORDER 805
606 BLOOD TRIGLYCERIDES INCREASED 804
607 BLOOD URINE PRESENT 804
608 CARDIOGENIC SHOCK 803
609 SPUTUM DISCOLOURED 803
610 FACET JOINT SYNDROME 802
611 EXOSTOSIS 801
612 VENTRICULAR FIBRILLATION 801
613 BONE MARROW FAILURE 797
614 MENTAL IMPAIRMENT 796
615 OSTEOMYELITIS 796
616 INTENTIONAL DOSE OMISSION 795
617 NEUTROPHIL COUNT INCREASED 795
618 FACIAL PAIN 794
619 RENAL HAEMANGIOMA 791
620 ANAPHYLACTIC SHOCK 790
621 BRONCHIECTASIS 790
622 UPPER LIMB FRACTURE 786
623 FULL BLOOD COUNT DECREASED 784
624 DEEP VEIN THROMBOSIS POSTOPERATIVE 783
625 COLITIS MICROSCOPIC 782
626 PHOTOSENSITIVITY REACTION 781
627 ROTATOR CUFF SYNDROME 779
628 ECONOMIC PROBLEM 777
629 MITRAL VALVE INCOMPETENCE 775
630 POST PROCEDURAL COMPLICATION 773
631 COLD SWEAT 763
632 TOOTHACHE 759
633 FACE OEDEMA 757
634 MIDDLE INSOMNIA 757
635 ORAL HERPES 757
636 MOOD ALTERED 756
637 PROCEDURAL PAIN 756
638 INTERVERTEBRAL DISC DEGENERATION 755
639 LUNG INFECTION 755
640 BLOOD IRON DECREASED 751
641 ADRENAL INSUFFICIENCY 750
642 SMALL INTESTINAL OBSTRUCTION 749
643 PARKINSON^S DISEASE 748
644 CORONARY ARTERY OCCLUSION 745
645 ANKLE FRACTURE 743
646 DIABETIC KETOACIDOSIS 743
647 FULL BLOOD COUNT ABNORMAL 742
648 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 742
649 INJECTION SITE MASS 741
650 PNEUMOTHORAX 740
651 PULMONARY CONGESTION 740
652 PLATELET COUNT INCREASED 738
653 SHOCK 735
654 THYROID DISORDER 733
655 GRIP STRENGTH DECREASED 732
656 IMPAIRED WORK ABILITY 732
657 CONJUNCTIVITIS 728
658 GLAUCOMA 728
659 PRODUCT DOSE OMISSION IN ERROR 726
660 OSTEONECROSIS 720
661 LOCAL SWELLING 719
662 BLOOD LACTATE DEHYDROGENASE INCREASED 718
663 DIABETIC NEPHROPATHY 717
664 THIRST 715
665 MYOCARDIAL ISCHAEMIA 713
666 NERVOUS SYSTEM DISORDER 713
667 PARAESTHESIA ORAL 713
668 DRUG EFFECT INCOMPLETE 710
669 SENSORY LOSS 706
670 CREATININE RENAL CLEARANCE DECREASED 705
671 RESPIRATORY ARREST 703
672 ANOSMIA 701
673 IMMUNODEFICIENCY 699
674 RHINITIS 699
675 COVID-19 PNEUMONIA 698
676 HEPATIC ENCEPHALOPATHY 697
677 PHARYNGITIS 693
678 ACCIDENTAL EXPOSURE TO PRODUCT 690
679 HYPERTENSIVE NEPHROPATHY 689
680 LARYNGITIS 689
681 MICTURITION URGENCY 689
682 TENDERNESS 689
683 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 687
684 MYOSITIS 686
685 SINUS TACHYCARDIA 684
686 TOXIC SKIN ERUPTION 682
687 INFUSION SITE PAIN 681
688 SPLENOMEGALY 681
689 ACTIVITIES OF DAILY LIVING IMPAIRED 679
690 BODY HEIGHT DECREASED 679
691 DERMATITIS ATOPIC 678
692 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 672
693 VAGINAL HAEMORRHAGE 670
694 DERMATITIS 668
695 MASS 668
696 CYANOSIS 667
697 FEELING JITTERY 665
698 GLOMERULAR FILTRATION RATE DECREASED 665
699 JOINT DISLOCATION 664
700 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 663
701 PROSTATE CANCER 663
702 BLOOD COUNT ABNORMAL 662
703 THERAPEUTIC RESPONSE SHORTENED 662
704 PHARYNGEAL OEDEMA 660
705 GLYCOSYLATED HAEMOGLOBIN INCREASED 657
706 APHONIA 656
707 APPENDICITIS 652
708 PARANOIA 650
709 BLOOD PRESSURE DIASTOLIC DECREASED 647
710 DEVICE RELATED INFECTION 646
711 HYPOAESTHESIA ORAL 645
712 TOOTH INFECTION 645
713 EJECTION FRACTION DECREASED 643
714 MOTOR DYSFUNCTION 641
715 PERIPHERAL COLDNESS 640
716 THINKING ABNORMAL 639
717 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 637
718 ABNORMAL LOSS OF WEIGHT 636
719 PRODUCT PRESCRIBING ERROR 636
720 LYMPHOPENIA 635
721 LUPUS-LIKE SYNDROME 633
722 MUSCULOSKELETAL DISORDER 633
723 PERITONITIS 633
724 SENSORY DISTURBANCE 633
725 URINE OUTPUT DECREASED 632
726 HEMIPLEGIA 630
727 NODULE 630
728 ORAL DISCOMFORT 630
729 TENSION HEADACHE 626
730 EXTRA DOSE ADMINISTERED 624
731 RALES 624
732 CARDIOVASCULAR DISORDER 622
733 PRODUCT STORAGE ERROR 621
734 SUPRAVENTRICULAR TACHYCARDIA 621
735 RENAL PAIN 619
736 GASTRIC CANCER 618
737 DISSEMINATED INTRAVASCULAR COAGULATION 616
738 UROSEPSIS 615
739 GENERALISED TONIC-CLONIC SEIZURE 613
740 MYOCLONUS 612
741 SKIN HAEMORRHAGE 610
742 CARDIAC MURMUR 609
743 PYELONEPHRITIS 605
744 SKIN CANCER 604
745 DISABILITY 600
746 HAEMODIALYSIS 599
747 METASTASES TO LIVER 598
748 GINGIVAL BLEEDING 596
749 INJECTION SITE RASH 595
750 SKIN FISSURES 595
751 WEIGHT FLUCTUATION 595
752 CARDIOMYOPATHY 594
753 DIVERTICULUM 594
754 SEDATION COMPLICATION 594
755 ILEUS 593
756 POLYURIA 592
757 EMPHYSEMA 590
758 INCONTINENCE 589
759 BLOOD ALBUMIN DECREASED 588
760 BRONCHOSPASM 588
761 GINGIVAL PAIN 588
762 SPINAL PAIN 587
763 TENDON RUPTURE 587
764 BODY TEMPERATURE DECREASED 586
765 FLUID OVERLOAD 586
766 MULTIPLE FRACTURES 586
767 MAJOR DEPRESSION 585
768 BREAST CANCER STAGE III 584
769 CYST 583
770 MUSCLE RIGIDITY 583
771 RHINITIS ALLERGIC 582
772 DISLOCATION OF VERTEBRA 581
773 DRUG ADMINISTRATION ERROR 579
774 HAEMORRHAGIC STROKE 578
775 EYE HAEMORRHAGE 577
776 WRIST FRACTURE 576
777 BACTERAEMIA 575
778 GASTROINTESTINAL PAIN 574
779 CHOLECYSTITIS CHRONIC 572
780 PURPURA 572
781 ATAXIA 571
782 HAEMORRHAGE INTRACRANIAL 571
783 MUSCLE SPASTICITY 571
784 ABSCESS 569
785 DELUSION 569
786 HYPERTHYROIDISM 569
787 SCAR 568
788 HYDRONEPHROSIS 567
789 MUSCLE TIGHTNESS 567
790 PREMATURE BABY 566
791 FLANK PAIN 563
792 LIVE BIRTH 563
793 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 560
794 HALLUCINATION, AUDITORY 557
795 MUSCLE ATROPHY 557
796 CHOLECYSTECTOMY 556
797 NAIL DISORDER 556
798 PHARMACEUTICAL PRODUCT COMPLAINT 556
799 CAROTID ARTERY OCCLUSION 555
800 ARTERIOSCLEROSIS 554
801 MANIA 554
802 HAIR COLOUR CHANGES 552
803 FRACTURE 551
804 EXPIRED PRODUCT ADMINISTERED 550
805 HEPATOMEGALY 550
806 SKIN IRRITATION 549
807 INCREASED APPETITE 548
808 BRAIN FOG 547
809 PRODUCT ADMINISTRATION ERROR 547
810 SKIN LACERATION 547
811 ANOREXIA 546
812 SUDDEN DEATH 546
813 HYPOKINESIA 545
814 TARDIVE DYSKINESIA 545
815 INTENTIONAL SELF-INJURY 543
816 HAIR TEXTURE ABNORMAL 542
817 ANAL INCONTINENCE 539
818 SINUS BRADYCARDIA 539
819 DEVICE DISLOCATION 538
820 TROPONIN INCREASED 536
821 CYTOMEGALOVIRUS INFECTION 535
822 PREGNANCY 534
823 WALKING AID USER 534
824 DIZZINESS POSTURAL 533
825 PNEUMONIA BACTERIAL 533
826 ATRIAL TACHYCARDIA 530
827 HYPERBILIRUBINAEMIA 530
828 ATRIAL FLUTTER 529
829 SKIN INFECTION 529
830 POLYP 528
831 NERVE INJURY 527
832 INTENTIONAL DRUG MISUSE 525
833 RESPIRATORY RATE INCREASED 525
834 X-RAY ABNORMAL 524
835 METASTASES TO BONE 523
836 ACUTE CORONARY SYNDROME 520
837 DENTAL CARIES 520
838 ARTERIAL OCCLUSIVE DISEASE 518
839 AFFECT LABILITY 517
840 OCULAR DISCOMFORT 517
841 RENAL FAILURE CHRONIC 516
842 LIGAMENT SPRAIN 515
843 PETECHIAE 515
844 PULMONARY ARTERIAL HYPERTENSION 515
845 INSURANCE ISSUE 513
846 ACUTE HEPATIC FAILURE 512
847 BLADDER DISORDER 511
848 HYPOALBUMINAEMIA 511
849 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 510
850 BLOOD URIC ACID INCREASED 510
851 SPINAL DISORDER 510
852 PHARYNGEAL SWELLING 509
853 TOOTH FRACTURE 509
854 MYOPATHY 508
855 GASTRIC HAEMORRHAGE 507
856 PAROSMIA 507
857 TACHYPNOEA 502
858 EXTRAPYRAMIDAL DISORDER 501
859 HEPATITIS CHOLESTATIC 501
860 SECRETION DISCHARGE 501
861 DRUG PRESCRIBING ERROR 499
862 DUODENAL ULCER 499
863 ERYTHEMA MULTIFORME 499
864 IRON DEFICIENCY 498
865 PRODUCT AVAILABILITY ISSUE 498
866 PSEUDOMONAS INFECTION 497
867 TOOTH LOSS 497
868 VENTRICULAR EXTRASYSTOLES 497
869 TONGUE DISORDER 496
870 DYSTONIA 495
871 EYE INFECTION 495
872 SPINAL COMPRESSION FRACTURE 495
873 TRICUSPID VALVE INCOMPETENCE 495
874 APATHY 494
875 BLOOD CALCIUM INCREASED 494
876 NERVE COMPRESSION 494
877 MYASTHENIA GRAVIS 493
878 VITAMIN D DECREASED 493
879 LUNG INFILTRATION 492
880 NEEDLE ISSUE 491
881 PRURITUS GENITAL 488
882 DRY THROAT 486
883 PELVIC PAIN 485
884 PULMONARY THROMBOSIS 485
885 ELECTROCARDIOGRAM ABNORMAL 482
886 SALIVARY HYPERSECRETION 482
887 INCREASED TENDENCY TO BRUISE 481
888 BACK INJURY 480
889 BEDRIDDEN 478
890 ULCER HAEMORRHAGE 476
891 UPPER-AIRWAY COUGH SYNDROME 476
892 SLEEP TERROR 474
893 PRE-EXISTING CONDITION IMPROVED 473
894 PARKINSONISM 472
895 PSYCHOMOTOR HYPERACTIVITY 472
896 HUNGER 471
897 TOOTH ABSCESS 471
898 LOWER GASTROINTESTINAL HAEMORRHAGE 469
899 DERMATITIS ALLERGIC 468
900 DERMATITIS CONTACT 468
901 POOR VENOUS ACCESS 468
902 SOPOR 467
903 FACIAL PARALYSIS 466
904 GROIN PAIN 466
905 MUSCLE STRAIN 466
906 INTESTINAL PERFORATION 464
907 ODYNOPHAGIA 463
908 PARALYSIS 462
909 TRANSFUSION 462
910 DIARRHOEA HAEMORRHAGIC 461
911 ESCHERICHIA INFECTION 461
912 ABNORMAL FAECES 460
913 INFUSION SITE ERYTHEMA 458
914 SHOCK HAEMORRHAGIC 458
915 COLON CANCER 457
916 MOUTH HAEMORRHAGE 457
917 ANURIA 456
918 PRODUCT ADMINISTRATION INTERRUPTED 456
919 SQUAMOUS CELL CARCINOMA 456
920 QUALITY OF LIFE DECREASED 455
921 ATRIOVENTRICULAR BLOCK COMPLETE 454
922 BLOOD GLUCOSE ABNORMAL 452
923 LEFT VENTRICULAR DYSFUNCTION 452
924 LARGE INTESTINE POLYP 450
925 LUPUS VULGARIS 450
926 COLITIS ISCHAEMIC 448
927 GASTRIC POLYPS 448
928 IMMUNE SYSTEM DISORDER 447
929 MYELODYSPLASTIC SYNDROME 446
930 ACUTE MYELOID LEUKAEMIA 444
931 CYSTIC FIBROSIS 444
932 INJECTION SITE URTICARIA 444
933 ARTERIOSCLEROSIS CORONARY ARTERY 441
934 BREATH SOUNDS ABNORMAL 441
935 INTESTINAL ISCHAEMIA 441
936 VITAMIN B12 DEFICIENCY 441
937 CHOLECYSTITIS ACUTE 440
938 NEUROTOXICITY 440
939 PSYCHOLOGICAL TRAUMA 439
940 EOSINOPHIL COUNT INCREASED 437
941 PLEURITIC PAIN 437
942 HYPERTENSIVE CRISIS 434
943 LYMPHOMA 434
944 PANCREATIC CARCINOMA 433
945 EAR DISCOMFORT 432
946 JOINT EFFUSION 432
947 DRUG TOLERANCE DECREASED 430
948 MALIGNANT MELANOMA 429
949 MADAROSIS 428
950 FAECALOMA 427
951 CARDIOSPASM 424
952 SCHIZOPHRENIA 424
953 BONE EROSION 423
954 NEUROLEPTIC MALIGNANT SYNDROME 423
955 PRODUCT PHYSICAL ISSUE 423
956 TEMPERATURE INTOLERANCE 423
957 INITIAL INSOMNIA 422
958 DERMATITIS BULLOUS 421
959 HYPOTHERMIA 421
960 MYOCARDITIS 421
961 OROPHARYNGEAL DISCOMFORT 421
962 PALMOPLANTAR KERATODERMA 421
963 POST-TRAUMATIC STRESS DISORDER 421
964 GASTROINTESTINAL INFECTION 420
965 HEPATITIS ACUTE 420
966 ACIDOSIS 419
967 HYPERTRANSAMINASAEMIA 419
968 TORSADE DE POINTES 419
969 INTERNAL HAEMORRHAGE 417
970 RASH VESICULAR 417
971 PEMPHIGOID 415
972 SPINAL OPERATION 415
973 RHEUMATOID NODULE 414
974 CHOLANGITIS 413
975 HAIR DISORDER 413
976 ORAL DISORDER 413
977 BLINDNESS UNILATERAL 411
978 PNEUMOCYSTIS JIROVECII PNEUMONIA 411
979 DECUBITUS ULCER 409
980 HOSPICE CARE 409
981 BRAIN OEDEMA 407
982 HICCUPS 407
983 TOOTH EXTRACTION 406
984 IMMUNOSUPPRESSION 405
985 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 404
986 DYSLIPIDAEMIA 404
987 URINARY TRACT DISORDER 404
988 GASTROINTESTINAL MOTILITY DISORDER 402
989 PELVIC FRACTURE 402
990 LIPASE INCREASED 401
991 EPIGASTRIC DISCOMFORT 400
992 GASTRITIS EROSIVE 399
993 BARRETT^S OESOPHAGUS 398
994 PRODUCT DISPENSING ERROR 398
995 ABDOMINAL TENDERNESS 397
996 EYELID OEDEMA 397
997 TENOSYNOVITIS 397
998 BIPOLAR DISORDER 396
999 AZOTAEMIA 394